Return
Engineered design of a pH-responsive, biocompatible Zn–MOF prodrug platform using 2-aminopurine anchoring as a pillar ligand
E
S
DOI:10.1016/j.apmt.2026.103254.png)
Abstract
En 中文
• The synthesis of a novel biocompatible MOF based on 2-aminopurine. • The synthesis of a pH-responsive prodrug with CHO modification of MTX and covalently attachment to the NH₂ groups of the bio-MOF. • The in vitro cumulative release evaluation in PBS solutions at pH of 5.0 and 7.4 to assess the role of the pH-sensitive CN bond.
Keywords:
biocompatible MOF
pH-responsive prodrug
2-aminopurine
Zn–MOF
drug delivery
Journal
IF:
6.9
Papers:
3.2K
Citations:
1.6W
Organization
No organization information available
